These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
372 related articles for article (PubMed ID: 19330166)
21. Seeing small molecules in action with bioorthogonal chemistry. Raghavan AS; Hang HC Drug Discov Today; 2009 Feb; 14(3-4):178-84. PubMed ID: 18973827 [TBL] [Abstract][Full Text] [Related]
22. Live-cell imaging with EosFP and other photoactivatable marker proteins of the GFP family. Wiedenmann J; Nienhaus GU Expert Rev Proteomics; 2006 Jun; 3(3):361-74. PubMed ID: 16771707 [TBL] [Abstract][Full Text] [Related]
23. Molecular imaging in the eye. Eter N Br J Ophthalmol; 2010 Nov; 94(11):1420-6. PubMed ID: 19713198 [TBL] [Abstract][Full Text] [Related]
24. Live-cell microscopy - tips and tools. Frigault MM; Lacoste J; Swift JL; Brown CM J Cell Sci; 2009 Mar; 122(Pt 6):753-67. PubMed ID: 19261845 [TBL] [Abstract][Full Text] [Related]
25. Super-resolution microscopy: going live and going fast. Lakadamyali M Chemphyschem; 2014 Mar; 15(4):630-6. PubMed ID: 24166886 [TBL] [Abstract][Full Text] [Related]
26. Real-time subcellular imaging in live animals: new visible targets for cancer drug discovery. Hoffman RM IDrugs; 2006 Sep; 9(9):632-5. PubMed ID: 16952071 [TBL] [Abstract][Full Text] [Related]
28. Biology calls the targets: combining RNAi and disease biology. van Es HH; Arts GJ Drug Discov Today; 2005 Oct; 10(20):1385-91. PubMed ID: 16253877 [TBL] [Abstract][Full Text] [Related]
29. [Development of in vivo imaging system targeting a molecular marker]. Furukawa T Gan To Kagaku Ryoho; 2008 Aug; 35(8):1269-71. PubMed ID: 18701835 [TBL] [Abstract][Full Text] [Related]
30. The promise of imaging biomarkers. Drug News Perspect; 2010 Mar; 23(2):119-23. PubMed ID: 20369077 [TBL] [Abstract][Full Text] [Related]
31. [Development of fluorescent in vivo imaging probes for cancers]. Tanaka S; Kizaka-Kondoh S Gan To Kagaku Ryoho; 2008 Aug; 35(8):1272-6. PubMed ID: 18701836 [TBL] [Abstract][Full Text] [Related]
33. The need for precompetitive integrative bionetwork disease model building. Friend SH Clin Pharmacol Ther; 2010 May; 87(5):536-9. PubMed ID: 20407459 [TBL] [Abstract][Full Text] [Related]
34. Function-first approaches to improve target identification in cancer. Kinch MS; Kohli M; Goldblatt M; Li WB Future Oncol; 2009 Jun; 5(5):617-23. PubMed ID: 19519202 [TBL] [Abstract][Full Text] [Related]
35. Unveiling the role of network and systems biology in drug discovery. Pujol A; Mosca R; Farrés J; Aloy P Trends Pharmacol Sci; 2010 Mar; 31(3):115-23. PubMed ID: 20117850 [TBL] [Abstract][Full Text] [Related]
36. Microscopic imaging techniques for drug discovery. Bullen A Nat Rev Drug Discov; 2008 Jan; 7(1):54-67. PubMed ID: 18079755 [TBL] [Abstract][Full Text] [Related]
37. Protein splicing: A versatile tool for drug discovery. Cheriyan M; Perler FB Adv Drug Deliv Rev; 2009 Sep; 61(11):899-907. PubMed ID: 19442693 [TBL] [Abstract][Full Text] [Related]
38. Imaging the live plant cell. Shaw SL Plant J; 2006 Feb; 45(4):573-98. PubMed ID: 16441350 [TBL] [Abstract][Full Text] [Related]
39. Cytomics: A multiparametric, dynamic approach to cell research. Herrera G; Diaz L; Martinez-Romero A; Gomes A; Villamón E; Callaghan RC; O'Connor JE Toxicol In Vitro; 2007 Mar; 21(2):176-82. PubMed ID: 16934431 [TBL] [Abstract][Full Text] [Related]